Setting up TRAPS

References

• McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, . Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133–44.
   PubMed Web of Science ®Google Scholar
• Galon J, Aksentijevich I, McDermott MF, O'Shea JJ, Kastner DL. TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol. 2000;12:479–86.
   PubMed Web of Science ®Google Scholar
• Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol. 2003;15:61–9.
   PubMed Web of Science ®Google Scholar
• Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol. 2005;17:586–99.
   PubMed Web of Science ®Google Scholar
• Ryan JG, Goldbach-Mansky R. The spectrum of autoinflammatory diseases: recent bench to bedside observations. Curr Opin Rheumatol. 2008;20:66–75.
   Google Scholar
• Simon A, van der Meer JWM. Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes. Am J Physiol Regul Integr Comp Physiol. 2007; 292:R86–98.
   Web of Science ®Google Scholar
• McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Medicine. 2006;8: 1242–8.
   Google Scholar
• Brydges S, Kastner DL. The systemic autoinflammatory diseases: Inborn errors of the innate immune system. Curr Top Microbiol Immunol. 2006;305:127–60.
   Web of Science ®Google Scholar
• Glaser RI, Goldbach-Mansky R. The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies. Curr Allergy Asthma Rep. 2008;8:288–98.
   PubMed Web of Science ®Google Scholar
• Bodar EJ, Drenth JPH, van der Meer JWM, Simon A. Dysregulation of innate immunity: hereditary periodic fever syndrome. Br J Haematol. 2009;144:279–302.
   Google Scholar
• Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: The molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009;27: 621–68.
   PubMed Web of Science ®Google Scholar
• Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ. Familial Hibernian fever. Q J Med. 1982;51:469–80.
   PubMedGoogle Scholar
• Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, . The TNF receptor-associated periodic syndrome (TRAPS). Emerging concepts of an autoinflammatory disorder. Medicine (Baltimore). 2002;81: 349–68.
   PubMed Web of Science ®Google Scholar
• Dodé C, André M, Bienvenu T, Hausfater P, Pêcheux C, Bienvenu J, . The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2002;46:2181–8.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S, . Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol. 2009;22:1051–8.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lucherini OM, Baldari CT, Laghi Pasini F, Galeazzi M. Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol. 2010;28:405–7.
   PubMed Web of Science ®Google Scholar
• Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HK, . Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 2003;48:2632–44.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lucherini OM, Cimaz R, Rigante D, Baldari CT, Laghi Pasini F, . Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series. Rheumatol Int. 2010 May 15 (Epub ahead of print).
   Google Scholar
• Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology. 2003;42:235–9.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Rigante D, Lucherini OM, Cimaz R, Laghi Pasini F, Baldari CT, . Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature. Int J Immunopathol Pharmacol. 2010;23:701–7.
   PubMed Web of Science ®Google Scholar
• Drewe E, Powell RJ. Novel treatments for tumor necrosis factor receptor-associated periodic syndrome (TRAPS): case history of experience with infliximab and sirolimus post etanercept. Clin Exp Rheumatol. 2002;4:S71.
   Google Scholar
• Jacobelli S, André M, Alexandra J-F, Dodé C, Papo T. Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology. 2007;46:1211–2.
   PubMed Web of Science ®Google Scholar
• Simon A, Bodar EJ, van der Hilst JC, van der Meer JWM, Fiselier TJ, Cuppen MP, . Beneficial response to interleukin 1 receptor antagonist in TRAPS. Am J Med. 2004;117:208–10.
   PubMed Web of Science ®Google Scholar
• Sacré K, Brihaye B, Lidove O, Papo T, Pocidalo M-A, Cuisset L, . Dramatic improvement following interleukin 1β blockade in tumour necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-α therapy. J Rheumatol. 2008;35:357–8.
   PubMed Web of Science ®Google Scholar
• Gattorno M, Pelagatti MA, Meini A, Obici L, Barcellona R, Federici S, . Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2008;58:1516–20.
   PubMed Web of Science ®Google Scholar
• Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487–501.
   PubMed Web of Science ®Google Scholar
• MacEwan DJ. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal. 2002;14:477–92.
   PubMed Web of Science ®Google Scholar
• Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45–65.
   PubMed Web of Science ®Google Scholar
• Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science. 2000;288:2351–4.
   PubMed Web of Science ®Google Scholar
• Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential complexes. Cell. 2003; 114:181–90.
   PubMed Web of Science ®Google Scholar
• Yazdanpanah B, Wiegmann K, Tchikov V, Krut O, Pongratz C, Schramm M, . Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature. 2009;460:1159-63.
   PubMed Web of Science ®Google Scholar
• Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27: 229–65.
   PubMed Web of Science ®Google Scholar
• Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693–733.
   PubMed Web of Science ®Google Scholar
• Ma Q. Transcriptional responses to oxidative stress: pathological and toxicological implications. Pharmacol Ther. 2010;125:376–93.
   PubMed Web of Science ®Google Scholar
• Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J, . Compartmentalization of TNF receptor 1 signaling: Internalized TNF receptosomes as death signaling vesicles. Immunity. 2004; 21:415–28.
   PubMed Web of Science ®Google Scholar
• Li L, Hailey DW, Soetandyo N, Li W, Lippincott-Schwartz J, Shu HB, . Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling. Biochim Biophys Acta. 2008;1783:1140–9.
   PubMed Web of Science ®Google Scholar
• Müllberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, . A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol. 1995;155:5198–205.
   PubMed Web of Science ®Google Scholar
• Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem. 1989;264:11974–80.
   PubMed Web of Science ®Google Scholar
• Todd I, Radford PM, Draper-Morgan K-A, McIntosh R, Bainbridge S, Dickinson P, . Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology. 2004;113:65–79.
   PubMed Web of Science ®Google Scholar
• Huggins ML, Radford PM, McIntosh RS, Bainbridge SE, Dickinson P, Draper-Morgan K-A, . Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor-receptor associated periodic syndrome. Differences between cell types. Arthritis Rheum. 2004;50:2651–9.
   PubMed Web of Science ®Google Scholar
• Siebert S, Amos N, Fielding CA, Wang EC, Aksentijevich I, Williams BD, . Reduced tumor necrosis factor signalling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum. 2005;52:1287–92.
   Google Scholar
• Stjernberg-Salmela S, Ranki A, Karenko L, Siitonen S, Mustonen H, Puolakkainen P, . Low TNF-induced NF-κB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology. 2010;49:382–90.
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, Galon J, Soares N, Mansfield E, Hull K, Oh HH, . The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet. 2001;69:301–14.
   PubMed Web of Science ®Google Scholar
• Kriegel MA, Hüffmeier U, Scherb E, Scheidig C, Geiler T, Kalden JR, . Tumor necrosis factor receptor-associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor implications for pathogenesis. Arthritis Rheum. 2003;48;2386–8.
   PubMed Web of Science ®Google Scholar
• Stojanov S, Dejaco C, Lohse P, Huss K, Duftner C, Belohradsky BH, . Clinical and functional of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumor necrosis factor receptor/associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann Rheum Dis. 2008;67:1292–8.
   PubMedGoogle Scholar
• Siebert S, Fielding CA, Williams BD, Brennan P. Mutations of the extracellular domain of tumour necrosis factor receptor I causes reduced NF-κB activation due to decreased surface expression. FEBS Lett. 2005;579:5193–8.
   PubMed Web of Science ®Google Scholar
• Nedjai B, Hitman GA, Yousaf N, Chernajovsky Y, Stjernberg-Salmela S, Pettersson T, . Abnormal tumor necrosis factor receptor I cell surface expression and NF-κB activation in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2008;58:273–83.
   PubMed Web of Science ®Google Scholar
• D'Osualdo A, Ferlito F, Prigione I, Obici L, Meini A, Zulian F, . Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum. 2006;54:998–1008.
   PubMed Web of Science ®Google Scholar
• Yousaf N, Gould DJ, Aganna E, Hammond L, Miriakian RM, Turner MD, . Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-κB activation. Arthritis Rheum. 2005;52:2906–16.
   PubMed Web of Science ®Google Scholar
• Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM, . Abnormal disulfide-linked oligomerization results in ER retention and altered signalling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood. 2006;108:1320–7.
   PubMed Web of Science ®Google Scholar
• Rebelo SL, Bainbridge SE, Amel-Kashipaz MR, Radford PM, Powell RJ, Todd I, . Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum. 2006;54:2674–87.
   PubMed Web of Science ®Google Scholar
• Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest. 2005;115: 2656–64.
   PubMed Web of Science ®Google Scholar
• Simon A, Park H, Maddipati R, Lobito AA, Bulua AC, Jackson AJ, . Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. Proc Natl Acad Sci U S A. 2010;107:9801–6.
   PubMed Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11:136–40.
   PubMed Web of Science ®Google Scholar
• Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal. 2007;9:2277–93.
   PubMed Web of Science ®Google Scholar
• Santos CX, Tanaka LY, Wosniak J, Laurindo FR. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid Redox Signal. 2009;11:2409–27.
   PubMed Web of Science ®Google Scholar
• Rebelo SL, Amel-Kashipaz MR, Radford PM, Bainbridge SE, Fiets R, Fang J, . Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line. Arthritis Rheum. 2009;60:8–11.
   Google Scholar
• Hull KM, Wong K, Wood GM, Chu WS, Kastner DL. Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction. Arthritis Rheum. 2002;46:2189–94.
   PubMed Web of Science ®Google Scholar
• Nowlan ML, Drewe E, Bulsara H, Esposito N, Robins RA, Tighe PJ, . Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology. 2006;45:31–7.
   PubMed Web of Science ®Google Scholar
• Kimberley FC, Lobito AA, Siegel RM, Screaton GR. Falling into TRAPS—receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther. 2007;9:217.
   PubMed Web of Science ®Google Scholar
• Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: A clinical perspective. Cell. 2010;140:784–9.
   PubMed Web of Science ®Google Scholar
• Quillinan N, Mohammad A, Mannion G, O'Keeffe D, Bergin D, Coughlan R, . Imaging evidence for persistent subclinical fasciitis and arthritis in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) between febrile attacks. Ann Rheum Dis. 2010;69:1408–9.
   PubMed Web of Science ®Google Scholar
• Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL. Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol. 2000;136:1487–94.
   PubMed Web of Science ®Google Scholar
• Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, . Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 2010;465:808–12.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140:900–17.
   PubMed Web of Science ®Google Scholar